- Establishment Labs ( NASDAQ: ESTA ) fell 18% in premarket trading after a new short report from Hindenburg Research.
- Hindenburg highlighted that the breast implant maker has had losses every year as a public company and that investors have given the company a "nosebleed" ~9.5x sales multiple. The report also takes issue with safety studies for the products.
- Establishment Labs ( ESTA ) didn't immediately return Seeking Alpha email request for comment.
- Establishment Labs ( ESTA ) has short interest of 11%.
- In August B Riley has initiated Establishment Labs ( ESTA ) with a buy rating, saying the natural aesthetic outcome of its Motiva breast implants will drive significant growth.
For further details see:
Establishment Labs drops 18% after new short report from Hindenburg Research